Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy

Phase 3

Withdrawn

• Conditions: Diabetic Retinopathy

• Registration Number: NCT00407108
• Lead Sponsor: Asociación para Evitar la Ceguera en México

Brief Summary

To investigate the feasibility and advantages of using perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting vitrectomy using a dual, dynamic drive (3D)technology. In complicated surgeries in advanced diabetic retinopathy and retinal detachment

Detailed Description

Not available

Study Timeline

• Study Start: 2006-03
• Primary Completion: 2006-03
• Study Completion: 2006-06
• Study First Submitted: 2006-06-30
• Study First Submitted QC: 2006-11-30
• Study First Posted: 2006-12-04
• Status Verified: 2024-05
• Last Update Submitted: 2024-05-29
• Last Update Posted: 2024-05-30

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Advanced diabetic retinopathy with retinal detachment

Exclusion Criteria

• Retinal detachments of more than 6 months

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Surgical time
Facility of surgical maneuvers

Trial Locations

Locations (1)

Asociación para Evitar la Ceguera en Mexico, Hospital "Luis Sanchez Bulnes"; 🇲🇽 Mexico City, Mexico DF, Mexico